POTENZA THERAPEUTICS
Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity. It was founded in 2014 and headquartered in Cambridge, Massachusetts.
POTENZA THERAPEUTICS
Industry:
Biopharma Biotechnology Oncology Therapeutics
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.potenzatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(617)588-4150
Email Addresses:
[email protected]
Total Funding:
35 M USD
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Founder
Investors List
InterWest Partners
InterWest Partners investment in Venture Round - Potenza Therapeutics
MPM Capital
MPM Capital investment in Venture Round - Potenza Therapeutics
Official Site Inspections
http://www.potenzatherapeutics.com
- Host name: ec2-3-130-253-23.us-east-2.compute.amazonaws.com
- IP address: 3.130.253.23
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Potenza Therapeutics"
Potenza Therapeutics Company Profile 2024: Valuation, …
The company's programs leverage novel biological insights into mechanisms by which cancer cells evade detection and destruction by the immune system, enabling medical practitioners to improve the health of patients through …See details»
Potenza Therapeutics - Craft
Dec 14, 2018 Potenza Therapeutics is a biotechnology company focused on building a diverse portfolio of oncology programs that utilize the body's own immune system to seek out, …See details»
Potenza Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Jun 18, 2023 Explore Potenza Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Technology Platform ...See details»
Potenza Therapeutics - Products, Competitors, Financials, …
Webinar Digitize remote site monitoring with Box Box will discuss how your life sciences organization can continue to propel therapies & devices through the value chain with faster …See details»
Astellas Acquires Potenza Therapeutics - Dec 14, 2018
Dec 14, 2018 TOKYO and NORTHBROOK, Ill., Dec. 14, 2018 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that it exercised, and closed on its exclusive …See details»
Potenza Therapeutics - Funding, Financials, Valuation & Investors
Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»
Potenza Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, …See details»
Organization | Potenza Therapeutics
Organization Overview. First Clinical Trial. 2017 NCT03260322. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Potenza Therapeutics Active Ingredients. Drugs in …See details»
Potenza Therapeutics Revenue, Growth & Competitor Profile
Potenza Therapeutics's annual revenues are $1 - $10 million (see exact revenue data) What industry is the company in? Potenza Therapeutics is classified as operating in the Scientific …See details»
Potenza Therapeutics, Inc. | CipherBio
Explore Potenza Therapeutics, Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Potenza Therapeutics - Overview, News & Similar companies
Who is Potenza Therapeutics. Potenza Therapeutics is a biotechnology company focused on building a diverse portfolio of oncology programs that utilize the body's own immune sys tem …See details»
Potenza Therapeutics - Contacts, Employees, Board Members
Organization. Potenza Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. …See details»
Potenza Therapeutics CEO and Key Executive Team | Craft.co
Potenza Therapeutics's President and Chief Executive Officer is Dan J. Hicklin. Other executives include David Cordo, CFO; Reid J. Leonard, COO and 3 others. See the full leadership team …See details»
Astellas Pharma and Potenza Therapeutics Partner to Build a …
Apr 21, 2015 Founded in 2014, Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own …See details»
Astellas gains three cancer drugs with $405m Potenza buy
Dec 14, 2018 Astellas has taken an option to acquire US biotech Potenza Therapeutics after the companies spent more than three years working together on cancer immunotherapies. The …See details»
Astellas Pharma Acquires Potenza Therapeutics
Dec 18, 2018 Astellas Pharma Inc. has exercised its exclusive option to acquire Potenza Therapeutics, Inc., paying $164.6 million upfront and additional payments of as much as …See details»
Astellas Pharma and Potenza Therapeutics Partner to Build a …
Founded in 2014, Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune …See details»
News | Astellas Pharma Inc.
Apr 22, 2015 Founded in 2014, Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own …See details»
Apogee Therapeutics | Best-in-Class Therapies for Immunological …
Apogee Therapeutics is a clinical stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory and immunology …See details»